LIVERFASt: Non-Invasive Liver Assessment for Chronic Hepatitis B & Diabetes
This publication introduces LIVERFASt, a non-invasive biomarker for predicting liver steatosis and fibrosis in patients with chronic Hepatitis B and […]
Your blog category
This publication introduces LIVERFASt, a non-invasive biomarker for predicting liver steatosis and fibrosis in patients with chronic Hepatitis B and […]
What Is Fatty Liver Disease? Fatty liver disease, now widely known as MASLD (Metabolic dysfunction-associated steatotic liver disease), is a
Fibronostics is pleased to announce its participation in the THASL 2025 Annual Conference, hosted by the Thai Association for the Study of the
When it comes to liver disease, early intervention isn’t just helpful, it’s critical. Known as the body’s “silent organ,” the
Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis, is primarily known for affecting the gastrointestinal tract. However,
High blood pressure doesn’t just strain your heart – it may quietly damage your liver too. Several studies, including a
Liver disease often progresses silently, with early stages showing minimal or no symptoms. However, the encouraging news is that these
Liver steatosis commonly known as fatty liver is no longer a silent bystander in liver health. It’s the central feature
When people think about liver disease, the conversation usually centers around fibrosis – the amount of permanent scarring in the
Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are conditions tied to the buildup of fat in